B2TJ22 AF NFT

Ribonuclease 3

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigdqxkdxi66wxaptizzezpvcjgieoidlahiqrmpjcj2hlz6arvgwe/metadata.json
IPFS of structure file: 
bafybeihxe65czhcgvg36ckldofqq4242shxyl4lj7dhv2pmpuehqbmdpgm/AF-B2TJ22-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xC26902D5844E7F183370B5392D064CE0247305cd
First NFT owner address (bech32): 
genesis1cf5s94vyfel3svmsk5uj6pjvuqj8xpwdc6zpl7
Current NFT ID #380269 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
380269
Accession (UniProt):
B2TJ22
Name::
Ribonuclease 3
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Eklund 17B / Type B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2TJ22 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2TJ22|RNC_CLOBB Ribonuclease 3 OS=Clostridium botulinum (strain Eklund 17B / Type B) OX=935198 GN=rnc PE=3 SV=1 MNRYKFNDIENRLGVYFNNPSLIKTALTHSSFGNQFKDAKYNERLEFLGDSVLQLCITEYLFNKFKDKSEGELTKIRSLIVCENSLYEIAKKLSLGEYIRMSKGEELTGGRERMSIQADAVEAVIAAVYLDKGIGFVNDFILLHFEEMINKAINNEIVLDFKTKLQELLQKDGEILIQYELVKYEGPPHRRKFFTNVIINEKVMGIGEGYSKKEAEQNAAKEALKRLEKNYE